Quality Control and Standardization of Ayurvedic Drugs: A Pharmaceutical Perspective
International Journal of Drug Delivery Technology · 05.06.2026 · 16 (49s)
DOI: 10.25258/ijddt.16.49s.67 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 05.06.2026. Verfasst von Sharat Vishwanath K und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Ayurvedic medicines are increasingly manufactured and evaluated within modern pharmaceutical systems, yet their quality control remains challenging because they include diverse herbal, polyherbal, fermented, lipid-based, mineral, metallic, and herbo-mineral dosage forms. This review critically examines quality control and standardization of Ayurvedic drugs from a pharmaceutical perspective, emphasizing that product quality must be built across the full lifecycle rather than confirmed only by finished-product testing. Major quality challenges arise from raw-material misidentification, seasonal and geographical variation, plant-part differences, post-harvest drying and storage, process variability, microbial contamination, pesticide residues, aflatoxins, heavy metals, residual solvents, synthetic adulterants, and inadequate packaging. The review highlights the need for Good Agricultural and Collection Practices, botanical and pharmacognostic authentication, physicochemical evaluation, DNA barcoding, validated chromatographic and spectroscopic methods, multi-marker analysis, metabolomics, chemometrics, GMP compliance, in-process controls, stability studies, safety evaluation, and pharmacovigilance. Particular attention is given to polyherbal and herbo-mineral formulations, where single-marker standardization and total metal estimation alone are scientifically insufficient. Instead, integrated approaches combining authenticated raw materials, process documentation, validated analytical fingerprints, contaminant testing, dosage-form-specific specifications, and post-market surveillance are required. The review also discusses Indian and international regulatory expectations, including pharmacopoeial standards, Schedule T GMP, quality dossiers, analytical validation, and safety monitoring. Overall, standardization is presented as a prerequisite for reproducibility, safety, regulatory acceptability, and credible research, but not as independent proof of clinical efficacy. The article therefore supports a balanced model that respects classical Ayurvedic pharmaceutics while applying modern pharmaceutical science, risk-based regulation, and evidence-oriented safety systems.
Zitieren
APA
K, S. V., Gaigole, A. S., Choudhary, A. S., Maharana, P., Meeradevi, T., Kumar, S., & Gopaiah, K. V. (2026). Quality Control and Standardization of Ayurvedic Drugs: A Pharmaceutical Perspective. International Journal of Drug Delivery Technology, 16(49s). https://doi.org/10.25258/ijddt.16.49s.67
Vancouver
K SV, Gaigole AS, Choudhary AS, Maharana P, Meeradevi T, Kumar S, et al. Quality Control and Standardization of Ayurvedic Drugs: A Pharmaceutical Perspective. International Journal of Drug Delivery Technology. 2026;16(49s). doi:10.25258/ijddt.16.49s.67
BibTeX
@article{K2026,
author = {K, Sharat Vishwanath and Gaigole, Aakanksha sharad and Choudhary, Ajab Singh and Maharana, Puspanjali and Meeradevi, T. and Kumar, Suresh and Gopaiah, K. Venkata},
title = {Quality Control and Standardization of Ayurvedic Drugs: A Pharmaceutical Perspective},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {49s},
doi = {10.25258/ijddt.16.49s.67}
}
EUVIMED